Tenofovir Based First Line Therapy in Newly Diagnosed Case of HIV Infection: An Experience from a Tertiary Care Hospital in India
Introduction: India has a huge burden of HIV/AIDS infection. Tenofovir based first line therapy is the preferred treatment for newly diagnosed cases with HIV infection.
Methodology: The present prospective study was done among newly diagnosed cases of HIV infection. The patients were followed up for a period of 6 months from the day of enrolment. Sociodemographic parameters, CD4 counts and adverse drug reactions were analysed at baseline and after 6 months. Bi-variate and multi-variate logistic regression was performed with the outcome variable as occurrence of adverse drug reactions.
Result: In this study, 67 patients were enrolled with mean age 32.75 (± 14.39) years. Mean CD4 count at start of treatment was 241.5/mm3. Mean difference in CD4 count was 383.05/mm3 (SD = 274.9). Dizziness, tingling, numbness of extremities and muscle cramps were most common adverse effects. On multi-variate logistic regression, occurrence of ADRs was seen to be significantly higher only in illiterate patients.
Conclusion: The present study highlights the importance of long-term follow-up of the patients on antiretroviral therapy. Adequate monitoring of the treatment parameters is of utmost importance.
Posted 01 Jun, 2020
Tenofovir Based First Line Therapy in Newly Diagnosed Case of HIV Infection: An Experience from a Tertiary Care Hospital in India
Posted 01 Jun, 2020
Introduction: India has a huge burden of HIV/AIDS infection. Tenofovir based first line therapy is the preferred treatment for newly diagnosed cases with HIV infection.
Methodology: The present prospective study was done among newly diagnosed cases of HIV infection. The patients were followed up for a period of 6 months from the day of enrolment. Sociodemographic parameters, CD4 counts and adverse drug reactions were analysed at baseline and after 6 months. Bi-variate and multi-variate logistic regression was performed with the outcome variable as occurrence of adverse drug reactions.
Result: In this study, 67 patients were enrolled with mean age 32.75 (± 14.39) years. Mean CD4 count at start of treatment was 241.5/mm3. Mean difference in CD4 count was 383.05/mm3 (SD = 274.9). Dizziness, tingling, numbness of extremities and muscle cramps were most common adverse effects. On multi-variate logistic regression, occurrence of ADRs was seen to be significantly higher only in illiterate patients.
Conclusion: The present study highlights the importance of long-term follow-up of the patients on antiretroviral therapy. Adequate monitoring of the treatment parameters is of utmost importance.